Drug Trial Radar · NCT07766499
A Study to Assess the Efficacy and Safety of THB335 in Adults With Chronic Spontaneous Urticaria (CSU)
Last checked: Nov 20, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
81
Planned (sponsor's estimate)
Start
Sep 15, 2026
Primary completion
Dec 31, 2027
Study completion Jan 31, 2028
Sponsor
- Lead sponsor
- Calixis Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 14, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
THB335-201 is a Phase 2, randomized, double-blind, placebo-controlled, parallel-group, multicenter study in adults with CSU who remain symptomatic despite standard-of-care treatment. The study includes a Screening Period of up to 4 weeks, a 12-week Treatment Period, and a 4-week Follow-Up Period, for a total participant duration of approximately 20 weeks.
Conditions
- Chronic Spontaneous Urticaria (CSU)
- Chronic Idiopathic Urticaria
Interventions
THB335 Lower DoseDrug
THB335 is an orally administered capsule added to a stable background regimen of a second generation H1 antihistamine.
THB335 Higher DoseDrug
THB335 is an orally administered capsule added to a stable background regimen of a second generation H1 antihistamine.
PlaceboDrug
Placebo is an orally administered capsule added to a stable background regimen of a second generation H1 antihistamine.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Weekly Urticaria Activity Score (UAS7) at Week 12Time frame: Baseline and Week 12
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
Calixis Study Site
Pasadena, California · Recruiting
Calixis Study Site
Ventura, California · Recruiting
Calixis Study Site
Walnut Creek, California · Recruiting
Calixis Study Site
Altamonte Springs, Florida · Recruiting
Calixis Study Site
Tampa, Florida · Recruiting
Calixis Study Site
Atlanta, Georgia · Recruiting
Calixis Study Site
Boise, Idaho · Recruiting
Calixis Study Site
Baton Rouge, Louisiana · Recruiting
Calixis Study Site
White Marsh, Maryland · Recruiting
Calixis Study Site
Wildwood, Missouri · Recruiting
Calixis Study Site
Asheville, North Carolina · Recruiting
Calixis Study Site
Smyrna, Tennessee · Recruiting
Calixis Study Site
Austin, Texas · Recruiting
Calixis Study Site
Houston, Texas · Recruiting
Calixis Study Site
Prosper, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.